Why the study?
To determine the relationship between amiodarone versus rate control medications and pulmonary function and survival in patients with postoperative atrial arrhythmias after bilateral lung transplant.
Does amiodarone improve pulmonary function and survival compared to rate control medications in patients with postoperative atrial arrhythmias after bilateral lung transplant?
Does amiodarone improve pulmonary function and survival compared to rate control medications in patients with postoperative atrial arrhythmias after bilateral lung transplant?
Amiodarone use for postoperative atrial arrhythmias after bilateral lung transplant does not negatively impact graft function at 12 months, though it was associated with lower survival odds.
Answers are grounded in this paper and cite their sources.
Amiodarone may warrant caution after lung transplant; observational data leave survival association hypothesis-generating.
The purpose of this study was to determine the relationship between use of amiodarone vs rate control medications and pulmonary function at 6 months and 12 months and survival in patients with postoperative atrial arrhythmias after bilateral lung transplant. Pulmonary function did not differ between groups when adjusting for baseline factors. Odds for being alive at 6 and 12 months were lower in the amiodarone group. Use of amiodarone for treatment of atrial arrhythmias after bilateral lung transplant was not related to graft function in the first 12 months and can reassure nurse practitioners on the use of amiodarone.
No takes yet. Share an insight, caveat, or question.
Cuffman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: